Neuroimaging of metastatic brain disease

Neurosurgery

Volumn 57, Issue 5 SUPPL., 2005, Pages

  Young, Robert J ^a   Sills, Allen K ^b   Brem, Steven ^c   Knopp, Edmond A ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Brain metastases; Magnetic resonance imaging; Positron emission tomography; Single photon emission computed tomography

Indexed keywords

ALANINE; CARBON 11; CHOLINE; CREATINE; CREATINE PHOSPHATE; CYSTEINE ETHYL ESTER TC 99M; GLUTAMIC ACID; GLUTAMINE; GLUTATHIONE; GLYCINE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; INOSITOL; IODINE 123; IODOTYROSINE; IOFETAMINE I 123; LACTIC ACID; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; N ACETYLASPARTIC ACID; NITROGEN 13; OXYGEN 15; TETROFOSMIN TC 99M; THALLIUM 201;

ANGIOGENESIS; BLOOD BRAIN BARRIER; BRAIN ABSCESS; BRAIN BLOOD FLOW; BRAIN CANCER; BRAIN HEMATOMA; BRAIN INFARCTION; BRAIN METASTASIS; BRAIN PERFUSION; DEMYELINATING DISEASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; GLIOMA; HUMAN; INTRAOPERATIVE PERIOD; ISOTOPE LABELING; MAGNETOENCEPHALOGRAPHY; MENINGIOMA; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION INJURY; REVIEW; SIGNAL NOISE RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; BRAIN ANGIOGRAPHY; BRAIN TUMOR; METASTASIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

BRAIN NEOPLASMS; CEREBRAL ANGIOGRAPHY; DIAGNOSTIC IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MAGNETOENCEPHALOGRAPHY; POSITRON-EMISSION TOMOGRAPHY;

EID: 27644455271     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/01.NEU.0000182774.54193.37     Document Type: Review

References (107)

1. Alger JR, Frank JA, Bizzi A, Fulham MJ, DeSouza BX, Duhaney MO, Inscoe SW, Black JL, van Zijl PC, Moonen CT: Metabolism of human gliomas: Assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 177:633-641, 1990.
2. Barker PB, Hearshen DO, Boska MD: Single-voxel proton MRS of the human brain at 1.5T and 3.0T. Magn Reson Med 45:765-769, 2001.
3. Ba-Ssalamah A, Schick S, Herneth AM, Cejna M, Schibany N, Prokesch RW, Wunderbaldinger P, Trattnig S: Preoperative fast MRI of brain tumors using three-dimensional segmented echo planar imaging compared to three-dimensional gradient echo technique. Magn Reson Imaging 18:635-640, 2000.
4. Bertossi M, Virgintino D, Maiorano E, Occhiogrosso M, Roncali L: Ultrastructural and morphometric investigation of human brain capillaries in normal and peritumoral tissues. Ultrastruct Pathol 21:41-49, 1997.
5. Bittar RG, Olivier A, Sadikot AF, Andermann F, Pike GB, Reutens DC: Presurgical motor and somatosensory cortex mapping with functional magnetic resonance imaging and positron emission tomography. J Neurosurg 91:915-921, 1999.
6. Black WC: High-dose MR in the evaluation of brain metastases: Will increased detection decrease costs? AJNR Am J Neuroradiol 15:1062-1064, 1994.
7. Bogomolny DL, Petrovich NM, Hou BL, Peck KK, Kim MJ, Holodny AI: Functional MRI in the brain tumor patient. Top Magn Reson Imaging 15:325-335, 2004.
8. Brannen JH, Badie B, Moritz CH, Quigley M, Meyerand ME, Haughton VM: Reliability of functional MR imaging with word-generation tasks for mapping Broca's area. AJNR Am J Neuroradiol 22:1711-1718, 2001.
9. Brasch R, Turetschek K: MRI characterization of tumors and grading angiogenesis using macromolecular contrast media: Status report. Eur J Radiol 34:148-155, 2000.
10. Castillo M, Kwock L: Proton MR spectroscopy of common brain tumors. Neuroimaging Clin N Am 8:733-752, 1998.
11. Castillo M, Kwock L, Scatliff J, Mukherji SK: Proton MR spectroscopy in neoplastic and non-neoplastic brain disorders. Magn Reson Imaging Clin N Am 6:1-20, 1998.
12. Cha S, Knopp EA, Johnson G, Wetzel SG, Litt AW, Zagzag D: Intracranial mass lesions: Dynamic contrast-enhanced susceptibility-weighted echoplanar perfusion MR imaging. Radiology 223:11-29, 2002.
13. Chamberlain MC, Kormanik PA: Prognostic significance of coexistent bulky metastatic central nervous system disease in patients with leptomeningeal metastases. Arch Neurol 54:1364-1368, 1997.
14. 18F-fluorodeoxyglucose. J Neurooncol 46:63-70, 2000.
15. Collie DA, Brush JP, Lammie GA, Grant R, Kunkler I, Leonard R, Gregor A, Sellar RJ: Imaging features of leptomeningeal metastases. Clin Radiol 54:765-771, 1999.
16. Daldrup H, Shames DM, Wendland M, Okuhata Y, Link TM, Rosenau W, Lu Y, Brasch RC: Correlation of dynamic contrast-enhanced MR imaging with histologic tumor grade: Comparison of macromolecular and small-molecular contrast media. AJR Am J Roentgenol 171:941-949, 1998.
17. 201Tl SPECT and CT in the follow-up of irradiated brain tumors. Int J Clin Oncol 9:51-58, 2004.
18. Davis TL, Kwong KK, Weisskoff RM, Rosen BR: Calibrated functional MRI: Mapping the dynamics of oxidative metabolism. Proc Natl Acad Sci USA 95:1834-1839, 1998.
19. Desprechins B, Stadnik T, Koerts G, Shabana W, Breucq C, Osteaux M: Use of diffusion-weighted MR imaging in differential diagnosis between intracerebral necrotic tumors and cerebral abscesses. AJNR Am J Neuroradiol 20:1252-1257, 1999.
20. 18F] fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool. Invest Radiol 22:360-371, 1987.
21. DiChiro G, Fulham MJ: Virchow's shackles: Can PET-FDG challenge tumor histology? AJNR Am J Neuroradiol 14:524-527, 1993.
22. Dorenbeck U, Butz B, Schlaier J, Bretschneider T, Schuierer G, Feuerbach S: Diffusion-weighted echo-planar MRI of the brain with calculated ADCs: A useful tool in the differential diagnosis of tumor necrosis from abscess? J Neuroimaging 13:330-338, 2003.
23. Earnest FT, Ryu JH, Miller GM, Luetmer PH, Forstrom LA, Burnett OL, Rowland CM, Swensen SJ, Midthun DE: Suspected non-small cell lung cancer: Incidence of occult brain and skeletal metastases and effectiveness of imaging for detection-Pilot study. Radiology 211:137-145, 1999.
24. 18F-fluorodeoxyglucose in patients with stereotactically irradiated brain metastases. Stereotact Funct Neurosurg 66[Suppl 1]:214-224, 1996.
25. Faisan S, Thoraval L, Armspach JP, Foucher JR, Metz-Lutz MN, Heitz F: Hidden Markov event sequence models: Toward unsupervised functional MRI brain mapping. Acad Radiol 12:25-36, 2005.
26. Fan G, Sun B, Wu Z, Guo Q, Guo Y: In vivo single-voxel proton MR spectroscopy in the differentiation of high-grade gliomas and solitary metastases. Clin Radiol 59:77-85, 2004.
27. Fellner F, Holl K, Held P, Fellner C, Schmitt R, Bohm-Jurkovic H: A T1-weighted rapid three-dimensional gradient-echo technique (MP-RAGE) in preoperative MRI of intracranial tumours. Neuroradiology 38:199-206, 1996.
28. Filippi M, Yousry T, Campi A, Kandziora C, Colombo B, Voltz R, Martinelli V, Spuler S, Bressi S, Scotti G, Comi G: Comparison of triple dose versus standard dose gadolinium-DTPA for detection of MRI enhancing lesions in patients with MS. Neurology 46:379-384, 1996.
29. FitzGerald DB, Cosgrove GR, Ronner S, Jiang H, Buchbinder BR, Belliveau JW, Rosen BR, Benson RR: Location of language in the cortex: A comparison between functional MR imaging and electrocortical stimulation. AJNR Am J Neuroradiol 18:1529-1539, 1997.
30. Freilich RJ, Krol G, DeAngelis LM: Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 38: 51-57, 1995.
31. Fulham MJ, Bizzi A, Dietz MJ, Shih HH, Raman R, Sobering GS, Frank JA, Dwyer AJ, Alger JR, DiChiro G: Mapping of brain tumor metabolites with proton MR spectroscopic imaging: Clinical relevance. Radiology 185:675-686, 1992.
32. Ganslandt O, Fahlbusch R, Nimsky C, Kober H, Moller M, Steinmeier R, Romstock J, Vieth J: Functional neuronavigation with magnetoencephalography: Outcome in 50 patients with lesions around the motor cortex. J Neurosurg 91:73-79, 1999.
33. Goldsher D, Litt AW, Pinto RS, Bannon KR, Kricheff II: Dural "tail" associated with meningiomas on Gd-DTPA-enhanced MR images: Characteristics, differential diagnostic value, and possible implications for treatment. Radiology 176:447-450, 1990.
34. Grossman R, Yousem D: Neuroradiology 2: The Requisites. Philadelphia, Mosby, 2003, pp 21-22.
35. Healy ME, Hesselink JR, Press GA, Middleton MS: Increased detection of inrracranial metastases with intravenous Gd-DTPA. Radiology 165:619-624, 1987.
36. Herrlinger U, Forschler H, Kuker W, Meyermann R, Bamberg M, Dichgans J, Weller M: Leptomeningeal metastasis: Survival and prognostic factors in 155 patients. J Neurol Sci 223:167-178, 2004.
37. Holodny AI, Schulder M, Ybasco A, Liu WC: Translocation of Broca's area to the contralateral hemisphere as the result of the growth of a left inferior frontal glioma. J Comput Assist Tomogr 26:941-943, 2002.
38. Isobe T, Matsumura A, Anno I, Yoshizawa T, Nagatomo Y, Itai Y, Nose T: Quantification of cerebral metabolites in glioma patients with proton MR spectroscopy using T2 relaxation time correction. Magn Reson Imaging 20:343-349, 2002.
39. Kashitani N, Makihara S, Maeda T, Eda R, Takeyama H, Hiraki Y: Thallium-201-chloride and technetium-99m-MIBI SPECT of primary and metastatic lung carcinoma. Oncol Rep 6:127-133, 1999.
40. Katano H, Karasawa K, Sugiyama N, Yamashita N, Ohkura A, Watanabe K, Kamiya K: Comparison of thallium-201 uptake and retention indices for evaluation of brain lesions with SPECT. J Clin Neurosci 9:653-658, 2002.
41. Kelly PJ, Daumas-Duport C, Scheithauer BW, Kall BA, Kispert DB: Stereotactic histologic correlations of computed tomography- and magnetic resonance imaging-defined abnormalities in patients with glial neoplasms. Mayo Clin Proc 62:450-459, 1987.
42. Kleinschmidt-DeMasters BK: Dural metastases: A retrospective surgical and autopsy series. Arch Pathol Lab Med 125:880-887, 2001.
43. Kremer S, Grand S, Berger F, Hoffmann D, Pasquier B, Remy C, Benabid AL, Bas JF: Dynamic contrast-enhanced MRI: Differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases. Neuroradiology 45:44-49, 2003.
44. Kremer S, Grand S, Remy C, Pasquier B, Benabid AL, Bracard S, Le Bas JF: Contribution of dynamic contrast MR imaging to the differentiation between durai metastasis and meningioma. Neuroradiology 46:642-648, 2004.
45. 18F FDG-positron emission tomography for presurgical planning: Comparison with electrical cortical stimulation. Acta Neurochir (Wien) 144:889-899, 2002.
46. Kuhn MJ, Hammer GM, Swenson LC, Youssef HT, Gleason TJ: MEI evaluation of "solitary" brain metastases with triple-dose gadoteridol: Comparison with contrast-enhanced CT and conventional-dose gadopentetate dimeglumine MEI studies in the same patients. Comput Med Imaging Graph 18:391-399, 1994.
47. Kwock L, Smith JK, Castillo M, Ewend MG, Cush S, Hensing T, Varia M, Morris D, Bouldin TW: Clinical applications of proton MR spectroscopy in oncology. Technol Cancer Res Treat 1:17-28, 2002.
48. Langleben DD, Segall GM: PET in differentiation of recurrent brain tumor from radiation injury. J Nucl Med 41:1861-1867, 2000.
49. Laothamatas J, Asavaphatiboon S, Sinlapawongsa T, Dhanachai M, Yongvithisatid P, Theerapancharoen V: MR spectroscopy and MR perfusion of brain tumors before and after radiation therapy: Preliminary results, in Kondziolka D (ed): Radiosurgery. Basel, Karger, 2004, pp 267-277.
50. Law M: MR spectroscopy of brain tumors. Top Magn Reson Imaging 15:291-313, 2004.
51. Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW: High-grade gliomas and solitary metastases: Differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715-721, 2002.
52. Law M, Oh S, Babb JS: Dynamic susceptibility contrast perfusion MR imaging of low-grade gliomas: Cerebral blood volume predicts patient outcome better than histopathy (in press).
53. Law M, Yang S, Babb JS, Knopp EA, Golfinos JG, Zagzag D, Johnson G: Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746-755, 2004.
54. Lee CC, Jack CR Jr, Riederer SJ: Mapping of the central sulcus with functional MR: Active versus passive activation tasks. AJNR Am J Neuroradiol 19:847-852, 1998.
55. Liotta LA, Stetler-Stevenson WG: Tumor invasion and metastasis: An imbalance of positive and negative regulation. Cancer Res 51:5054s-5059s, 1991.
56. Long DM: Capillary ultrastructure in human metastatic brain tumors. J Neurosurg 51:53-58, 1979.
57. Lu S, Ahn D, Johnson G, Cha S: Peritumoral diffusion tensor imaging of high-grade gliomas and metastatic brain tumors. AJNR Am J Neuroradiol 24:937-941, 2003.
58. Maki DD, Grossman RI: Patterns of disease spread in metastatic breast carcinoma: Influence of estrogen and progesterone receptor status. AJNR Am J Neuroradiol 21:1064-1066, 2000.
59. Mamata Y, Mamata H, Nabavi A, Kacher DF, Pergolizzi RS Jr, Schwartz RB, Kikinis R, Jolesz FA, Maier SE: Intraoperative diffusion imaging on a 0.5 Tesla interventional scanner. J Magn Reson Imaging 13:115-119, 2001.
60. 111Indium-diethylenetriamine pentaacetic acid cerebrospinal fluid flow studies predict distribution of intrathecally administered chemotherapy and outcome in patients with leptomeningeal metastases. Neurology 50:438-444, 1998.
61. Masters LT, Pryor JC, Nelson PK: Angiographic findings associated with intra-axial intracranial tumors. Neuroimaging Clin N Am 6:739-749, 1996.
62. Nabavi A, Black PMcL, Gering DT, Westin CF, Mehta V, Pergolizzi RS Jr, Ferrant M, Warfield SK, Hata N, Schwartz RB, Wells WM III, Kikinis R, Jolesz FA: Serial intraoperative magnetic resonance imaging of brain shift. Neurosurgery 48:787-797, 2001.
63. Nakau H, Miyazawa T, Tamai S, Tsuchiya K, Shima K, Shirotani T, Chigasaki H: Pathologic significance of meningeal enhancement ("flare sign") of meningiomas on MEI. Surg Neurol 48:584-590, 1997.
64. Negendank WG, Sauter R, Brown TR, Evelhoch JL, Falini A, Gotsis ED, Heerschap A, Kamada K, Lee BC, Mengeot MM, Moser E, Padavic-Shaller KA, Sanders JA, Spraggins TA, Stillman AE, Terwey B, Vogl TJ, Wicklow K, Zimmerman RA: Proton magnetic resonance spectroscopy in patients with glial tumors: A multicenter study. J Neurosurg 84:449-458, 1996.
65. 1H MRSI. NMR Biomed 12:123-138, 1999.
66. Nimsky C, Ganslandt O, Cerny S, Hastreiter P, Greiner G, Fahlbusch R: Quantification of, visualization of, and compensation for brain shift using intraoperative magnetic resonance imaging. Neurosurgery 47:1070-1079, 2000.
67. Nimsky C, Ganslandt O, Hastreiter P, Wang R, Benner T, Sorensen AG, Fahlbusch R: Preoperative and intraoperative diffusion tensor imaging-based fiber tracking in glioma surgery. Neurosurgery 56:130-137, 2005.
68. Ogawa S, Menon RS, Tank DW, Kim SG, Merkle H, Ellermann JM, Ugurbil K: Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging: A comparison of signal characteristics with a biophysical model. Biophys J 64:803-812, 1993.
69. Petrovich NM, Holodny AI, Brennan CW, Gutin PH: Isolated translocation of Wernicke's area to the right hemisphere in a 62-year-man with a temporo-parietal glioma. AJNR Am J Neuroradiol 25:130-133, 2004.
70. Pham CD, Roberts TP, van Bruggen N, Melnyk O, Mann J, Ferrara N, Cohen RL, Brasch RC: Magnetic resonance imaging detects suppression of tumor vascular permeability after administration of antibody to vascular endothelial growth factor. Cancer Invest 16:225-230, 1998.
71. Price CJ, Veltman DJ, Ashburner J, Josephs O, Friston KJ: The critical relationship between the timing of stimulus presentation and data acquisition in blocked designs with fMRI. Neuroimage 10:36-44, 1999.
72. Rabinov JD, Lee PL, Barker FG, Louis DN, Harsh GR IV, Cosgrove GR, Chiocca EA, Thornton AF, Loeffler JS, Henson JW, Gonzalez RG: In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: Initial experience. Radiology 225:871-879, 2002.
73. Rezai AR, Hund M, Kronberg E, Zonenshayn M, Cappell J, Ribary U, Kall B, Llinas R, Kelly PJ: The interactive use of magnetoencephalography in stereotactic image-guided neurosurgery. Neurosurgery 39:92-102, 1996.
74. Richiello A, Sparano L, Del Basso De Caro ML, Russo G: Dural metastasis mimicking falx meningioma: Case report. J Neurosurg Sci 47:167-171, 2003.
75. Rumana CS, Hess KR, Shi WM, Sawaya R: Metastatic brain tumors with durai extension. J Neurosurg 89:552-558, 1998.
76. Russell EJ, Geremia GK, Johnson CE, Huckman MS, Ramsey RG, Washburn-Bleck J, Turner DA, Norusis M: Multiple cerebral metastases: Detectability with Gd-DTPA-enhanced MR imaging. Radiology 165:609-617, 1987.
77. Schaefer PW, Grant PE, Gonzalez RG: Diffusion-weighted MR imaging of the brain. Radiology 217:331-345, 2000.
78. Schiffbauer H, Berger MS, Ferrari P, Freudenstein D, Rowley HA, Roberts TP: Preoperative magnetic source imaging for brain tumor surgery: A quantitative comparison with intraoperative sensory and motor mapping. J Neurosurg 97:1333-1342, 2002.
79. Seitz RJ, Huang Y, Knorr U, Tellmann L, Herzog H, Freund HJ: Large-scale plasticity of the human motor cortex. Neuroreport 6:742-744, 1995.
80. Sheehan J, Niranjan A, Flickinger JC, Kondziolka D, Lunsford LD: The expanding role of neurosurgeons in the management of brain metastases. Surg Neurol 62:32-40, 2004.
81. Shimizu H, Kumabe T, Shirane R, Yoshimoto T: Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. AJNR Am J Neuroradiol 21:659-665, 2000.
82. Singh SK, Leeds NE, Ginsberg LE: MR imaging of leptomeningeal metastases: Comparison of three sequences. AJNR Am J Neuroradiol 23:817-821, 2002.
83. Stadnik TW, Chaskis C, Michotte A, Shabana WM, van Rompaey K, Luypaert R, Budinsky L, Jellus V, Osteaux M: Diffusion-weighted MR imaging of intracerebral masses: Comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol 22:969-976, 2001.
84. Stegman LD, Rehemtulla A, Beattie B, Kievit E, Lawrence TS, Blasberg RG, Tjuvajev JG, Ross BD: Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy. Proc Natl Acad Sci U S A 96:9821-9826, 1999.
85. Straathof CS, de Bruin HG, Dippel DW, Vecht CJ: The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis. J Neurol 246:810-814, 1999.
86. Sze G, Johnson C, Kawamura Y, Goldberg SN, Lange R, Friedland RJ, Wolf RJ: Comparison of single- and triple-dose contrast material in the MR screening of brain metastases. AJNR Am J Neuroradiol 19:821-828, 1998.
87. Sze G, Milano E, Johnson C, Heier L: Detection of brain metastases: Comparison of contrast-enhanced MR with unenhanced MR and enhanced CT. AJNR Am J Neuroradiol 11:785-791, 1990.
88. Tamiya T, Kinoshita K, Ono Y, Matsumoto K, Furuta T, Ohmoto T: Proton magnetic resonance spectroscopy reflects cellular proliferative activity in astrocytomas. Neuroradiology 42:333-338, 2000.
89. Togawa T, Yui N, Kinoshita F, Yanagisawa M, Namba H: A study on thallium-201 SPECT in brain metastases of lung cancer: With special reference to tumor size and tumor to normal brain thallium uptake ratio [in Japanese]. Kaku Igaku 32:217-225, 1995.
90. Tseng SH, Liao CC, Lin SM, Chen Y, Shun CT: Durai metastasis in patients with malignant neoplasm and chronic subdural hematoma. Acta Neurol Scand 108:43-46, 2003.
91. Tung GA, Evangelista P, Rogg JM, Duncan JA III: Diffusion-weighted MR imaging of rim-enhancing brain masses: Is markedly decreased water diffusion specific for brain abscess? AJR Am J Roentgenol 177:709-712, 2001.
92. Urenjak J, Williams SR, Gadian DG, Noble M: Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 59:55-61, 1992.
93. 1H NMR spectroscopy in vivo and in vitro. J Comput Assist Tomogr 18:705-713, 1994.
94. Valk PE, Budinger TF, Levin VA, Silver P, Gutin PH, Doyle WK: PET of malignant cerebral tumors after interstitial brachytherapy: Demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg 69:830-838, 1988.
95. Veltman DJ, Mechelli A, Friston KJ, Price CJ: The importance of distributed sampling in blocked functional magnetic resonance imaging designs. Neuroimage 17:1203-1206, 2002.
96. Voorhies RM, Sundaresan N, Thaler HT: The single supratentorial lesion: An evaluation of preoperative diagnostic tests. J Neurosurg 53:364-368, 1980.
97. Weisskoff RM, Zuo CS, Boxerman JL, Rosen BR: Microscopic susceptibility Variation and transverse relaxation: Theory and experiment. Magn Reson Med 31:601-610, 1994.
98. Wetzel SG, Cha S, Law M, Johnson G, Golfinos J, Lee P, Nelson PK: Preoperative assessment of intracranial tumors with perfusion MR and a volumetric interpolated examination: A comparative study with DSA. AJNR Am J Neuroradiol 23:1767-1774, 2002.
99. Wheless JW, Castillo E, Maggio V, Kim HL, Breier JI, Simos PG, Papanicolaou AC: Magnetoencephalography (MEG) and magnetic source imaging (MSI). Neurologist 10:138-153, 2004.
100. Wilms G, Lammens M, Marchal G, Demaerel P, Verplancke J, Van Calenbergh F, Coffin J, Plets C, Baert AL: Prominent dural enhancement adjacent to nonmeningiomatous malignant lesions on contrast-enhanced MR images. AJNR Am J Neuroradiol 12:761-764, 1991.
101. Wunderbaldinger P, Bogdanov A, Weissleder R: New approaches for imaging in gene therapy. Eur J Radiol 34:156-165, 2000.
102. 201Tl SPET in the detection of recurrent brain tumours after radiation therapy. Nucl Med Commun 23:1183-1190, 2002.
103. Yetkin FZ, Papke RA, Mark LP, Daniels DL, Mueller WM, Haughton VM: Location of the sensorimotor cortex: Functional and conventional MR compared. AJNR Am J Neuroradiol 16:2109-2113, 1995.
104. Yokoi K, Kamiya N, Matsuguma H, Machida S, Hirose T, Mori K, Tominaga K: Detection of brain metastasis in potentially operable non-small cell lung cancer: A comparison of CT and MRI. Chest 115:714-719, 1999.
105. Yuh WT, Engelken JD, Muhonen MG, Mayr NA, Fisher DJ, Ehrhardt JC: Experience with high-dose gadolinium MR imaging in the evaluation of brain metastases. AJNR Am J Neuroradiol 13:335-345, 1992.
106. Yuh WT, Tali ET, Nguyen HD, Simonson TM, Mayr NA, Fisher DJ: The effect of contrast dose, imaging time, and lesion size in the MR detection of intracerebral metastasis. AJNR Am J Neuroradiol 16:373-380, 1995.
107. Zeiser R, Burger JA, Bley TA, Windfuhr-Blum M, Schulte-Monting J, Behringer DM: Clinical follow-up indicates differential accuracy of magnetic resonance imaging and immunocytology of the cerebral spinal fluid for the diagnosis of neoplastic meningitis: A single centre experience. Br J Haematol 124:762-768, 2004.